CPRX
Price
$19.93
Change
+$0.29 (+1.48%)
Updated
Aug 8, 11:48 AM (EDT)
Capitalization
2.4B
89 days until earnings call
PLX
Price
$1.52
Change
+$0.01 (+0.66%)
Updated
Aug 8, 10:50 AM (EDT)
Capitalization
120.21M
10 days until earnings call
Interact to see
Advertisement

CPRX vs PLX

Header iconCPRX vs PLX Comparison
Open Charts CPRX vs PLXBanner chart's image
Catalyst Pharmaceuticals
Price$19.93
Change+$0.29 (+1.48%)
Volume$6.74K
Capitalization2.4B
Protalix BioTherapeutics
Price$1.52
Change+$0.01 (+0.66%)
Volume$600
Capitalization120.21M
CPRX vs PLX Comparison Chart in %
Loading...
CPRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CPRX vs. PLX commentary
Aug 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CPRX is a Buy and PLX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 08, 2025
Stock price -- (CPRX: $19.64 vs. PLX: $1.51)
Brand notoriety: CPRX and PLX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CPRX: 280% vs. PLX: 73%
Market capitalization -- CPRX: $2.4B vs. PLX: $120.21M
CPRX [@Biotechnology] is valued at $2.4B. PLX’s [@Biotechnology] market capitalization is $120.21M. The market cap for tickers in the [@Biotechnology] industry ranges from $199.59B to $0. The average market capitalization across the [@Biotechnology] industry is $2.29B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CPRX’s FA Score shows that 1 FA rating(s) are green whilePLX’s FA Score has 1 green FA rating(s).

  • CPRX’s FA Score: 1 green, 4 red.
  • PLX’s FA Score: 1 green, 4 red.
According to our system of comparison, CPRX is a better buy in the long-term than PLX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CPRX’s TA Score shows that 4 TA indicator(s) are bullish while PLX’s TA Score has 3 bullish TA indicator(s).

  • CPRX’s TA Score: 4 bullish, 4 bearish.
  • PLX’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, CPRX is a better buy in the short-term than PLX.

Price Growth

CPRX (@Biotechnology) experienced а -7.95% price change this week, while PLX (@Biotechnology) price change was +3.42% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.05%. For the same industry, the average monthly price growth was +6.42%, and the average quarterly price growth was +12.36%.

Reported Earning Dates

CPRX is expected to report earnings on Nov 05, 2025.

PLX is expected to report earnings on Aug 18, 2025.

Industries' Descriptions

@Biotechnology (+0.05% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CPRX($2.4B) has a higher market cap than PLX($120M). PLX has higher P/E ratio than CPRX: PLX (30.20) vs CPRX (13.21). CPRX YTD gains are higher at: -5.918 vs. PLX (-19.681). CPRX has higher annual earnings (EBITDA): 269M vs. PLX (7.16M). CPRX has more cash in the bank: 581M vs. PLX (34.7M). CPRX has less debt than PLX: CPRX (3.09M) vs PLX (5.24M). CPRX has higher revenues than PLX: CPRX (535M) vs PLX (59.8M).
CPRXPLXCPRX / PLX
Capitalization2.4B120M2,003%
EBITDA269M7.16M3,756%
Gain YTD-5.918-19.68130%
P/E Ratio13.2130.2044%
Revenue535M59.8M895%
Total Cash581M34.7M1,674%
Total Debt3.09M5.24M59%
FUNDAMENTALS RATINGS
CPRX vs PLX: Fundamental Ratings
CPRX
PLX
OUTLOOK RATING
1..100
678
VALUATION
overvalued / fair valued / undervalued
1..100
55
Fair valued
65
Fair valued
PROFIT vs RISK RATING
1..100
27100
SMR RATING
1..100
3466
PRICE GROWTH RATING
1..100
5264
P/E GROWTH RATING
1..100
967
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CPRX's Valuation (55) in the Pharmaceuticals Other industry is in the same range as PLX (65) in the Servicestothe Health Industry industry. This means that CPRX’s stock grew similarly to PLX’s over the last 12 months.

CPRX's Profit vs Risk Rating (27) in the Pharmaceuticals Other industry is significantly better than the same rating for PLX (100) in the Servicestothe Health Industry industry. This means that CPRX’s stock grew significantly faster than PLX’s over the last 12 months.

CPRX's SMR Rating (34) in the Pharmaceuticals Other industry is in the same range as PLX (66) in the Servicestothe Health Industry industry. This means that CPRX’s stock grew similarly to PLX’s over the last 12 months.

CPRX's Price Growth Rating (52) in the Pharmaceuticals Other industry is in the same range as PLX (64) in the Servicestothe Health Industry industry. This means that CPRX’s stock grew similarly to PLX’s over the last 12 months.

PLX's P/E Growth Rating (7) in the Servicestothe Health Industry industry is significantly better than the same rating for CPRX (96) in the Pharmaceuticals Other industry. This means that PLX’s stock grew significantly faster than CPRX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CPRXPLX
RSI
ODDS (%)
Bullish Trend 1 day ago
85%
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
71%
Bullish Trend 1 day ago
80%
Momentum
ODDS (%)
Bearish Trend 1 day ago
73%
Bearish Trend 1 day ago
74%
MACD
ODDS (%)
Bullish Trend 1 day ago
69%
N/A
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
70%
Bullish Trend 1 day ago
81%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
63%
Bullish Trend 1 day ago
80%
Advances
ODDS (%)
Bullish Trend 4 days ago
80%
Bullish Trend 1 day ago
84%
Declines
ODDS (%)
Bearish Trend 1 day ago
69%
Bearish Trend 8 days ago
80%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
89%
N/A
Aroon
ODDS (%)
Bearish Trend 1 day ago
75%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
CPRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LZESX12.20N/A
N/A
Lazard International Equity Select Open
ETHSX12.31N/A
N/A
Eaton Vance Worldwide Health Sci A
ACAZX43.90N/A
N/A
Alger Capital Appreciation Z
JOPSX14.05N/A
N/A
JOHCM International Opps Institutional
MLRSX13.52-0.07
-0.52%
NYLI Winslow Large Cap Growth Class R6

PLX and

Correlation & Price change

A.I.dvisor indicates that over the last year, PLX has been loosely correlated with IOVA. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if PLX jumps, then IOVA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PLX
1D Price
Change %
PLX100%
+2.03%
IOVA - PLX
50%
Loosely correlated
+2.33%
STOK - PLX
31%
Poorly correlated
+0.61%
ZNTL - PLX
31%
Poorly correlated
+2.84%
CPRX - PLX
31%
Poorly correlated
-9.89%
SNDX - PLX
31%
Poorly correlated
-1.32%
More